Therefore, we survey the average frequency of genetic alterations corresponding to each signaling protein in the EGFR network across PAAD, LUAD, LUSC, HNSCC, and COAD tumors in TCGA (Figure 1B). The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.